Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

10x Genomics, Inc. Director's Dealing 2019

Sep 12, 2019

31830_dirs_2019-09-11_c9f05436-941c-4eb0-9574-4503fa2ee5e1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2019-09-11

Reporting Person: Venrock Associates VI, L.P. (10% Owner)
Reporting Person: Venrock Partners VI, L.P. (10% Owner)
Reporting Person: Venrock Management VI, LLC (10% Owner)
Reporting Person: Venrock Partners Management VI, LLC (10% Owner)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Series A-2 Preferred Stock $ Class B Common Stock (7819645) Indirect
Series B Preferred Stock $ Class B Common Stock (3272171) Indirect

Footnotes

F1: The Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock shall automatically convert into Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock.

F2: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, all outstanding shares of Class B Common Stock will convert automatically into Class A Common Stock upon any transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation.

F3: This Form 3 reflects the reclassification of each share of (i) Historical Class B Common Stock into one share of Class A Common Stock and (ii) Historical Class A Common Stock into one share of Class B Common Stock, in each case, to be effected immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock.

F4: Represents (a) 7,250,375 shares of Class B common stock held by Venrock Associates VI, L.P. ("VA VI") and (b) 569,270 shares of Class B common stock held by Venrock Partners VI, L.P. ("VP VI"). Venrock Management VI, LLC ("VM VI"), is the sole general partner of VA VI. Venrock Partners Management VI, LLC ("VPM VI"), is the sole general partner of VP VI. VM VI and VPM VI expressly disclaim beneficial ownership over all shares held by VA VI and VP VI, except to the extent of their indirect pecuniary interests therein.

F5: Represents (a) 3,033,957 shares of Class B common stock held by VA VI and (b) 238,214 shares of Class B common stock held by VP VI. VM VI is the sole general partner of VA VI. VPM VI is the sole general partner of VP VI. VM VI and VPM VI expressly disclaim beneficial ownership over all shares held by VA VI and VP VI, except to the extent of their indirect pecuniary interests therein.